AkzoNobel expands Performance Coatings research facility in Houston

Article

The upgraded facility will support the company's Protective Coatings, Marine Coatings and Specialty Coatings businesses. Completion is due in early 2016.

PRESS RELEASE

The upgraded facility will support the company’s Protective Coatings, Marine Coatings and Specialty Coatings businesses. Completion is due in early 2016.

“The expanded facility will provide a central, state-of-the-art technical resource for our businesses in the US, creating the critical mass for effective R&D to efficiently support our customers,” said Aidan Mernin, RD&I Director for Protective Coatings.

The expanded facility will be able to house up to 35 laboratory staff, with 30 skilled technologists employed initially. Key capabilities will include a dedicated area for experimental paint making, a modern paint application laboratory and environmentally controlled drying areas for conditioning of test panels. Enhanced chemical resistance testing will also be available to support the Ceilcote and Enviroline linings ranges in North America.

“This investment underlines our focus on technology and product innovation and providing technical support for our customers,” said Mauricio Bannwart, Managing Director of AkzoNobel’s Protective Coatings business. “It will be an integral part of our global RD&I function and will directly contribute to our overall growth plans.”

Related Videos
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Image credit: motortion | stock.adobe.com - Young depressed woman talking to lady psychologist during session, mental health
Image credit:  JPC-PROD | stock.adobe.com - Choosing method of contraception : Birth control pills, an injection syringe, condom, IUD-method, on grey
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.